CURRENT REPORT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 8, 2006
 
Altair Nanotechnologies Inc.
(Exact Name of Registrant as Specified in its Charter)
 

Canada
  
1-12497
  
33-1084375
(State or other jurisdiction of 
incorporation or organization)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)

 
204 Edison Way Reno, NV
  
89502 
(Address of Principal Executive Offices)
  
(Zip Code)
  
Registrant's Telephone Number, Including Area Code:
(801) 858-3750
 
N/A 
(Former name, former address, and formal fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
r
   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
r
   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
r
   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
r
   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
 
 
Item 2.02 Results of Operations and Financial Condition.

On November 8, 2006, Altair Nanotechnologies, Inc. (the "Company") issued a press release entitled "Altair Nanotechnologies Revenues Rise 28 Percent in Third Quarter.” The full text of the press release is provided herewith as Exhibit 99.1.

The information in Item 2.02 of this Report (including exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits.
 
99.1  Press Release issued by the Company dated November 8, 2006

 
2
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  Altair Nanotechnologies Inc.
 
 		  
 		  
 
Dated: November 8, 2006  By:   /s/ Edward Dickinson
 
Edward Dickinson, Chief Financial Officer

 
 
 

 
3